Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,980.00
-20.00 (-0.33%)
At close: Feb 13, 2026

Sinil Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
68,03073,14987,71196,840128,314247,300
Market Cap Growth
-11.01%-16.60%-9.43%-24.53%-48.11%229.18%
Enterprise Value
30,14841,17369,84473,664110,106234,589
Last Close Price
5980.006430.007485.328067.4710558.8920160.16
PE Ratio
6.115.126.437.9719.2132.78
PS Ratio
0.840.820.981.212.084.03
PB Ratio
0.450.500.650.791.132.30
P/TBV Ratio
0.450.510.660.801.152.33
P/FCF Ratio
8.555.9356.5629.0316.41109.40
P/OCF Ratio
5.133.225.797.0811.5022.36
EV/Sales Ratio
0.370.460.780.921.783.82
EV/EBITDA Ratio
1.581.983.614.078.8021.22
EV/EBIT Ratio
2.542.714.995.3913.8035.43
EV/FCF Ratio
3.793.3445.0422.0814.08103.77
Debt / Equity Ratio
0.000.000.000.000.000.00
Debt / EBITDA Ratio
0.020.020.030.010.020.04
Debt / FCF Ratio
0.040.040.350.040.040.17
Net Debt / Equity Ratio
-0.25-0.23-0.17-0.19-0.18-0.13
Net Debt / EBITDA Ratio
-1.99-1.60-1.18-1.28-1.64-1.28
Net Debt / FCF Ratio
-4.76-2.70-14.75-6.96-2.63-6.28
Asset Turnover
0.490.560.600.590.490.51
Inventory Turnover
1.952.152.422.402.222.33
Quick Ratio
3.993.323.272.953.463.44
Current Ratio
5.634.714.864.224.865.08
Return on Equity (ROE)
7.67%10.16%10.57%10.28%6.05%7.23%
Return on Assets (ROA)
4.49%5.98%5.92%6.28%3.93%3.41%
Return on Invested Capital (ROIC)
8.94%11.69%12.04%11.77%6.88%6.75%
Return on Capital Employed (ROCE)
7.60%10.20%10.10%10.80%6.80%5.80%
Earnings Yield
16.63%19.55%15.55%12.55%5.21%3.05%
FCF Yield
11.70%16.85%1.77%3.45%6.09%0.91%
Payout Ratio
19.42%13.74%8.15%8.89%15.73%14.92%
Buyback Yield / Dilution
0.02%0.02%-3.94%1.05%0.11%2.91%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.